Should gastroenterologists prescribe cannabis? The highs, the lows and the unknowns
Authors:
Open Access
- 26 June 2023
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 11 (18) , 4210-4230
Abstract
Cannabis, commonly known as marijuana, is a drug extracted from the Cannabis plant known for its psychotropic and medicinal properties. It has been used for healing purposes during ancient times, although its psychoactive components led to its restricted use in medicine. Nonetheless, cannabis is found to have modulatory effects on the endocannabinoid system exhibiting its medicinal role in the gastrointestinal (GI) system. Emerging animal and human studies demon strate the influential effects of cannabis on a variety of GI diseases including inflammatory bowel disease, motility disorders and GI malignancies. It also has a regulatory role in GI symptoms including nausea and vomiting, anorexia, weight gain, abdominal pain, among others. However, both its acute and chronic use can lead to undesirable side effects such as dependency and addiction, cognitive impairment and cannabinoid hyperemesis syndrome. We will discuss the role of cannabis in the GI system as well as dosing strategies to help guide gastroenterologists to assess its efficacy and provide patient counseling before prescription of medical marijuana.Keywords
This publication has 129 references indexed in Scilit:
- Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients With Nonconstipated Irritable Bowel SyndromeGastroenterology, 2011
- Regulation of nausea and vomiting by cannabinoidsBritish Journal of Pharmacology, 2011
- Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanismCell Death & Disease, 2011
- Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory studyPsychopharmacology, 2010
- Activity-Dependent Regulation of Synapses by Retrograde MessengersNeuron, 2009
- Effect of Δ9‐tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humansBritish Journal of Pharmacology, 2008
- Cannabidiol, extracted fromCannabis sativa, selectively inhibits inflammatory hypermotility in miceBritish Journal of Pharmacology, 2008
- Influence of Cannabis Use on Severity of Hepatitis C DiseaseClinical Gastroenterology and Hepatology, 2008
- Cannabinoids in pancreatic cancer: Correlation with survival and painInternational Journal of Cancer, 2007
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1and CB2receptor agonistsin vitroBritish Journal of Pharmacology, 2007